Full-Time

Technical Sourcing Mechanical Engineer 3

Thermo Fisher Scientific

Thermo Fisher Scientific

10,001+ employees

Supplies laboratory instruments, reagents, diagnostics

No salary listed

Madison, WI, USA

In Person

On-site role in Madison, Wisconsin; no remote work.

Bachelor's, Master's

Category
Mechanical Engineering (1)
Required Skills
Mechatronics
Product Design
SolidWorks

Get referred to Thermo Fisher Scientific

See people who can refer or advise you

Requirements
  • Education: Bachelor’s or Master’s in Mechanical Engineering, Mechatronics, Electrical Engineering, or Physics. Equivalent field are also acceptable.
  • BS with 5+ years experience, or MS with 3+ years’ experience: hands on product design, product development, and manufacturing experience
  • Expertise in Mechanical assembly design or cast, machined, and sheet-metal part design.
  • Strong project management skills with a consistent track record.
  • Experience leading vendors, contract manufacturers, and design firms.
  • Proficiency in value engineering, process development, should-cost modeling, and DFA/DFM/DFx methodologies.
  • Demonstrated ability to manage electromechanical suppliers and contract manufacturers.
  • Knowledgeable in regulatory standards such as FDA, NSF, CSA, UL, ISO 13485 in the medical products industry.
  • Skilled in CAD Design software such as SolidWorks, Pro/e, or equivalent.
Responsibilities
  • Collaborate with R&D, product development, quality, procurement, and strategic sourcing to align the global sourcing strategy.
  • Successfully conduct cost reduction and manufacturing scale-up initiatives.
  • Resolve supplier quality issues to maintain our detailed production standards.
  • Focus primarily on mechanical components, assemblies, fabricated sheet metal parts, cast and machined parts, and OEM assemblies.
  • Travel up to 20% globally to support and coordinate supplier activities and projects.
Desired Qualifications
  • Medical devices experience is helpful.
  • An understanding of phase gate development processes across diverse teams is helpful.
Thermo Fisher Scientific

Thermo Fisher Scientific

View

Thermo Fisher Scientific provides life sciences tools and services for research, healthcare, and industry. Its products include laboratory instruments, reagents, consumables, and software for activities like protein biology, PCR, sequencing, and bioprocessing. It differentiates itself with an end-to-end footprint across trusted brands and strong customer support and education, plus direct sales and promotions. Its goal is to help make the world healthier, cleaner, and safer by enabling discovery, diagnostics, and quality manufacturing across research institutions, healthcare providers, and government bodies.

Company Size

10,001+

Company Stage

IPO

Headquarters

Waltham, Massachusetts

Founded

1956

Get referred to Thermo Fisher Scientific

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • July 23, 2026 raised guidance to $47.4-$48.1 billion after 10% Q2 growth.
  • India customer base targets 15%-20% growth over five years, expanding field sales.
  • July 2026 FDA clearance for EXENT and new centrifuge launches deepen recurring demand.

What critics are saying

  • August 2026 CVE-2026-17583 lets attackers tamper with HID DNA evidence files.
  • Microbiology divestiture closes in Q3 2026, cutting 2026 revenue about $200 million.
  • Middleton layoffs and facility closure signal restructuring pressure; one forensic scandal destroys court trust.

What makes Thermo Fisher Scientific unique

  • Thermo Fisher’s breadth spans instruments, reagents, diagnostics, and services across workflows.
  • Orbitrap, EXENT, and Oncomine tie research tools directly into regulated clinical use.
  • Global installed base and compliance know-how lock in pharma, hospital, and government customers.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Unlimited Paid Time Off

Paid Vacation

Paid Sick Leave

Paid Holidays

Hybrid Work Options

401(k) Retirement Plan

401(k) Company Match

Employee Stock Purchase Plan

Fertility Treatment Support

Family Planning Benefits

Professional Development Budget

Conference Attendance Budget

Wellness Program

Mental Health Support

Gym Membership

Phone/Internet Stipend

Home Office Stipend

Company News

WebWire
Aug 11th, 2026
XPO appoints Jonas Svedlund as chief legal officer.

XPO appoints Jonas Svedlund as chief legal officer. Greenwich, Conn. - WEBWIRE - Tuesday, August 11, 2026 XPO (NYSE: XPO), a leading provider of freight transportation in North America, announced that Jonas Svedlund has joined the company as chief legal officer, effective immediately. He will lead the company's legal and compliance functions, including corporate governance and commercial matters. Mario Harik, chairman and chief executive officer of XPO, said, "Jonas is an accomplished executive who will help advance our strategic priorities. He brings deep legal expertise and a proven ability to partner with organizational leaders at every level. He is an excellent addition to our leadership team and I'm pleased to welcome him to XPO." Svedlund most recently served as deputy general counsel for Thermo Fisher Scientific, where he oversaw the company's corporate and commercial legal functions. Earlier, he held various executive roles during more than a decade with General Electric, including serving as general counsel for two separate GE businesses. He began his career as a corporate attorney with Sullivan & Cromwell. Svedlund holds a juris doctor degree from Harvard Law School and a bachelor's degree from the University of California, Berkeley. About XPO XPO, Inc. (NYSE: XPO) is a leader in asset-based less-than-truckload (LTL) freight transportation in North America. The company's customer-focused organization efficiently moves 16 billion pounds of freight per year, enabled by its proprietary technology. XPO serves 55,000 customers with 586 locations and 38,000 employees in North America and Europe, and is headquartered in Greenwich, Conn., USA. Visit xpo.com for more information, and connect with XPO on LinkedIn, Facebook, X, Instagram and YouTube. WebWireID358731 This news content was configured by WebWire editorial staff. Linking is permitted. Distribute your news. * Every day, hundreds of individuals and companies choose WebWire to distribute their news. * WebWire places your news within numerous highly trafficked news search engines generating leads and publicity. * Submit Your Release Now!

Yahoo Finance
Aug 10th, 2026
Thermo Fisher raises guidance as life sciences recovery broadens vs Danaher's uneven rebound

Thermo Fisher Scientific and Danaher, two major life sciences tools companies, both reported better-than-expected second-quarter results, but their recoveries show different trajectories. Thermo Fisher posted 10% revenue growth to $11.99 billion and 13% adjusted EPS growth to $6.03. The company raised guidance citing broad-based demand improvement across pharmaceutical and biotechnology markets. Its Life Sciences Solutions segment grew 13% year-over-year, whilst Analytical Instruments returned to growth after nearly two years of weak demand. Danaher's recovery remains more uneven, though it achieved high-single-digit adjusted EPS growth with improving core growth versus the previous quarter. Thermo Fisher's recovery appears more broad-based across multiple segments, suggesting greater durability. The company continues investing in product innovation, including new Orbitrap mass spectrometers.

NAPA
Aug 5th, 2026
Suit says faith foiled by fossil fuels in 401(k) funds.

Suit says faith foiled by fossil fuels in 401(k) funds. A new 401(k) suit alleges employment discrimination for refusing to offer investment options that don't invest in fossil fuels. A new 401(k) suit alleges employment discrimination in a refusal to offer investment options that don't invest in fossil fuels. The plaintiff here[i] is Dr. Andrew Hartley, a statistical science director at Thermo Fisher Scientific Inc., and the suit accuses his employer of discriminating against him and refusing to accommodate his religious beliefs in violation of Title VII[ii] and the New York State Human Rights Law. The suit asserts that he is a devout Christian and member of the United Methodist Church, and that he sincerely believes[iii] that investing his retirement money in "ecologically and socially destructive" fossil fuel companies violates his religious beliefs. The suit (Hartley v. Thermo Fisher Scientific Inc., case number 1:26-cv-01612, in the U.S. District Court for the Western District of New York) further asserts that due to the reality that Thermo Fisher's current equity-based retirement plan options maintain significant investments in fossil-fuel companies, he is "...forced to either compromise his religious beliefs or forego a significant component of his employer-provided benefit." The suit claims that Hartley requested that his employer "provide him with an accommodation that would allow him to partake of the benefits of his 401(k) plan in a manner consistent with his faith" - and that he "provided Thermo Fisher with a list of several funds that are frequently available on 401(k) menus and that are consistent with his beliefs, and asked that the company make one of them (or a similar fund of the company's choosing) available on the 401(k) plan menu." The suit notes that Thermo Fisher acknowledged receipt of the accommodation request "...but, despite multiple attempts to follow up and initiate negotiations, Thermo Fisher has failed to offer any accommodation or reason why such accommodation cannot be provided". Arguing that Hartley has been "subjected to persistent discrimination and denial of reasonable accommodations due to his religion," the suit says it wants to compel Thermo Fisher to "cease its unlawful discriminatory practices, implement effective policies to prevent religious discrimination, provide reasonable accommodations as required by law, and compensate him for the damages he has suffered as a result of Thermo Fisher's actions." Stay tuned. - Nevin E. Adams, JD [i] Hartley is represented by Kathleen Konopka of ClientEarth USA Inc. [ii] Title VII defines religion to include "all aspects of religious observance and practice, as well as belief," and requires an employer to accommodate its employees' religious beliefs "unless an employer demonstrates that he is unable to reasonably accommodate an employee's or prospective employee's religious observance or practice without undue hardship on the conduct of the employer's business." [iii] The suit asserts that "Dr. Hartley believes his Christian faith commands him to care for and steward the earth, and that actively investing in and profiting from fossil fuel companies whose work directly harms the earth, and its inhabitants, violates his religious obligations." Please log in or create a free account to comment on this article. Share to: Publish date: August 05, 2026 By: Sponsored by MFS

News4Hackers
Aug 4th, 2026
Critical vulnerability in DNA forensic software threatens 30 years of evidence.

Critical vulnerability in DNA forensic software threatens 30 years of evidence. Post Views: 14 Researchers have identified a significant security flaw in forensic software used by U.S. crime laboratories, risking DNA evidence from 1995 onward. Discovery of the vulnerability. Researchers have identified a significant security flaw in forensic software utilized by major U.S. crime laboratories, which could enable unauthorized modifications to DNA evidence dating back to 1995. The vulnerability, uncovered by a team of forensic and computer scientists, allows an AI-driven approach to alter digital representations of genetic data without detection. Impact on forensic evidence. Although the software vendor, Thermo Fisher Scientific, has not reported any confirmed breaches, the researchers emphasize that methods to detect such tampering remain elusive. A systems engineer demonstrated the exploit within an hour, gaining access to encrypted data. The potential for malicious actors to manipulate DNA profiles raises concerns about wrongful convictions or unjust acquittals. Broader implications. Experts highlight that forensic science has lagged in implementing robust security protocols compared to other sectors, resulting in inconsistent safeguards across more than 200 laboratories. Thermo Fisher Scientific has acknowledged the issue and is developing a software update incorporating digital signatures to ensure data integrity moving forward. Technical details of the exploit. The flaw specifically enables the manipulation of digital scans generated since 1995, leveraging machine learning techniques to introduce undetectable alterations. This capability could allow adversaries to introduce or remove genetic markers, undermining the reliability of forensic conclusions. Researchers noted that the exploit bypasses existing verification mechanisms, leaving no clear audit trail for investigators. Response and mitigation efforts. The discovery underscores broader challenges in securing legacy systems within the forensic sector, where rapid technological advancements have outpaced the adoption of modern cybersecurity practices. Thermo Fisher Scientific confirmed the vulnerability and stated that the upcoming update will include cryptographic validation to prevent unauthorized data modifications. However, the lack of immediate mitigation measures has prompted calls for urgent review of evidence-handling protocols. Long-Term concerns. The incident also raises questions about the long-term integrity of genetic databases, which contain records critical to both criminal investigations and civil cases. The findings align with growing concerns about the intersection of artificial intelligence and forensic science, as emerging technologies introduce new vectors for exploitation. Cybersecurity experts urge forensic institutions to prioritize proactive risk assessments and collaborate with software developers to address systemic vulnerabilities.

IT Security News
Aug 4th, 2026
Thermo Fisher DNA analysis software flaw lets attackers secretly alter test data.

Thermo Fisher DNA analysis software flaw lets attackers secretly alter test data. 2026-08-04 07:08 Thermo Fisher Scientific has released security updates for a high-severity flaw in its Applied Biosystems Human Identification (HID) software. This vulnerability could allow nearly undetectable manipulation of DNA test data files before analysis. The issue, tracked as CVE-2026-17583, carries a CVSS v4 score of 8.2 and affects .fsa and .hid file outputs used in forensic [...] Read the original article: Thermo Fisher Scientific has disclosed a high-severity security flaw affecting several of its Applied Biosystems Human Identification (HID) software... Secure email service August 3, 2026 In "Cyber Security News"